Naistentautien ja synnytysten yksikkö
Department of Obstetrics and Gynaecology

Julkaisut 2000
Publications 2000

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Anttila M. Biological Predictors of Disease Progression and Patient Survival in Epithelial Ovarian Cancer.
2 Anttila MA et al. Expression of transcription factor AP-2 alfa predicts survival in epithelial ovarian cancer.
3 Anttila MA et al. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.
4 Aukee P, Penttinen J. Pöksyt märkänä - mikä neuvoksi?
5 Eloranta M-L et al. Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG.
6 Eloranta M-L et al. Apolipoprotein E alleles in women with intrahepatic cholestasis of pregnancy.
7 Heikkilä A et al. Maternal serum second trimester AFP and hCG in pregnancies with placenta previa.
8 Heikkinen AM et al. Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women?
9 Heinonen S. Raskauden ajan seulonnat.
10 Heinonen S, Kirkinen P. Pregnancy outcome after previous stillbirth resulting from causes other than maternal conditions and fetal abnormalities.
11 Heinonen S et al. Etiology and outcome of second trimester non-immune fetal hydrops.
12 Helin H, Kirkinen P. Laparoscopic ultrasonography during conservative ovarian surgery.
13 Helisalmi S et al. Is the presenilin-1 E318G missense mutation a risk factor for Alzheimer´s disease?
14 Jensen TK et al. Semen quality among Danish and Finnish men attempting to conceive.
15 Kallinen J et al. Prenatal diagnosis of fragile X syndrome and the risk of expansion of a premutation.
16 Kallinen J et al. Pregnancy outcome in carriers of fragile X.
17 Kantola M et al. Accumulation of cadmium, zinc, and copper in maternal blood and developmental placental tissue: differences between Finland, Estonia, and St. Petersburg.
18 Kantola M et al. Selenium levels in placental tissue and in maternal blood in first and third trimester of pregnancy.
19 Keski-Nisula L et al. Intrauterine inflammation at term: a histopathologic study.
20 Kirkinen P. Vuoto ja kipu varhaisraskaudessa.
21 Kirkinen P. Ultraäänitutkimus gynekologiassa.
22 Kirkinen P et al. Antepartum findings in fetal protein C deficiency.
23 Komulainen M et al. Identification of early postmenopausal women with no bone response to HRT; results of a 5-year clinical trial.
24 Kurvinen K et al. Variants of the long control region of human papillomavirus type 16.
25 Launonen V et al. Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables.
26 Makkonen N et al. Obstetric prognosis in second pregnancy after preeclampsia in first pregnancy.
27 Ordén M-R et al. Contrast-enhanced sonography in the examination of benign and malignant adnexal masses.
28 Ordén M-R et al. Contrast-enhanced ultrasonography of uteroplacental circulation does not evoke harmful ctg changes or perinatal events.
29 Paakki P et al. Antepartum glucocorticoid therapy suppresses human placental xenobiotic and steroid metabolizing enzymes.
30 Paakki P et al. Maternal drug abuse and human term placental xenobiotic and steroid metabolizing enzymes in vitro.
31 Poutamo J et al. Diagnosing fetal urinary tract abnormalities: benefits of MRI compared to ultrasonography.
32 Salmén T et al. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in finnish women: effect of hormone replacement therapy.
33 Salmén T et al. Estrogeenireseptorigeenin polymorfia vaikuttaa luun menetyksen nopeuteen ja hormonikorvaushoidon tehoon menopaussin jälkeen.
34 Salmén T et al. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alfa genotype in early postmenopausal women.

Naistentautien ja synnytysten yksikkö Department of Obstetrics and Gynaecology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008